CRESTOR

Patient support

Providing your patients with help and support is a goal that AstraZeneca shares with your practice. This section contains educational materials and consumer communications that may help you give your patients the information they need.


Important safety information about CRESTOR

1

CRESTOR is contraindicated in patients with a known hypersensitivity to any component of this product, in patients with active liver disease, which may include unexplained persistent elevations of hepatic transaminase levels, in women who are or may become pregnant, and in nursing mothers.



Please see full Prescribing Information for CRESTOR.

CRESTOR was licensed from SHIONOGI & CO. LTD, Osaka, Japan.

CRESTOR is a registered trademark of the AstraZeneca group of companies.
259343  3/08 ©2008 AstraZeneca Pharmaceuticals LP. All rights reserved.
US Flag
This product information is intended for
US health care professionals only.